Common Equity: The sum of all common equity items.
Rosetta Genomics Ltd. (ROSGQ) had Common Equity of $1.10M for the most recently reported fiscal quarter, ending 2017-06-30.
| Income Statement Financials | |
$0.87M |
|
$-2.07M |
|
$0.57M |
|
$0.30M |
|
$2.24M |
|
$-1.37M |
|
$-0.23M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-2.07M |
|
$-1.14M |
|
$-1.37M |
|
$-1.37M |
|
2.55M |
|
2.55M |
|
$0.81 |
|
$0.81 |
|
| Balance Sheet Financials | |
$5.68M |
|
$0.52M |
|
$0.53M |
|
$6.21M |
|
$2.71M |
|
$0.04M |
|
$2.39M |
|
$5.11M |
|
|
Common Equity |
$1.10M |
$1.10M |
|
$1.10M |
|
2.59M |
|
| Cash Flow Statement Financials | |
$-7.05M |
|
$-0.02M |
|
$1.26M |
|
$6.16M |
|
$1.32M |
|
$-4.39M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
0.03 |
|
0.08 |
|
34.60% |
|
-157.59% |
|
-157.59% |
|
-- |
|
-131.26% |
|
-238.05% |
|
$-7.07M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
0.88 |
|
102.10 |
|
-103.91% |
|
-103.91% |
|
-18.40% |
|
-100.53% |
|
$0.42 |
|
$-2.77 |
|
$-2.77 |
|